Dx Deals: Veracyte Acquires Convergent Genomics for up to $180 Million
The deal gives the oncology-focused Veracyte a boost in bladder cancer detection

Subscribe to view Essential
Start a Free Trial for immediate access to this article
The deal gives the oncology-focused Veracyte a boost in bladder cancer detection

Start a Free Trial for immediate access to this article